经导管心脏瓣膜病介入治疗临床试验数据最新进展
Transcatheter Valve Trial Data Update
09/26 13:30-15:00
主会场-国际场（5楼 水晶厅-Ⅰ+Ⅳ） (Main Arena-International (5F Crystal Hall-Ⅰ+Ⅳ))
-
金仕生物提供学术支持
-
13:30-15:00
-
13:30-15:00
-
13:30-13:33
-
13:33-13:41自扩张干瓣 TAVI 系统ProStyle 用于治疗主动脉瓣狭窄的3年随访结果Three-year outcomes after TAVI in aortic stenosis with the dry-tissue self-expanding ProStyle system
-
13:41-13:45讨论与互动Discussion and audience interaction
-
13:45-13:53自扩张式 TAVI系统 VenusA-Valve 用于治疗主动脉瓣狭窄的10年随访结果Ten-year outcomes after TAVI in aortic stenosis with the self-expanding VenusA-Valve system
-
13:53-13:57讨论与互动Discussion and audience interaction
-
13:57-14:05自扩张式 TAVI 系统 VitaFlow 用于治疗主动脉瓣狭窄9年随访结果Nine-year outcomes after TAVI in aortic stenosis with the motorized self-expanding VitaFlow system
-
14:05-14:09讨论与互动Discussion and audience interaction
-
14:09-14:17TaurusTrio 经股 TAVI 系统用于单纯主动脉瓣反流：ALTER-AR 研究1年随访结果TAVI in pure aortic regurgitation with the TaurusTrio system: one-year outcomes of the ALTER-AR study
-
14:17-14:21讨论与互动Discussion and audience interaction
-
14:21-14:29TAVI 的真实世界结果：中国多中心 CARRY II 研究的启示Real-world outcomes of TAVI in China: insights from the multicenter CARRY II study
-
14:29-14:33讨论与互动Discussion and audience interaction
-
14:33-14:41VenusP-Valve TPVI 系统的长期临床效果：来自中国 NMPA 和欧盟 CE 认证研究的数据Long-term outcomes after TPVI with the VenusP-Valve system: data from NMPA and CE studies
-
14:41-14:45讨论与互动Discussion and audience interaction
-
14:45-14:53DragonFly 二尖瓣 TEER 系统在退行性和功能性二尖瓣反流中的临床效果Performance of the DragonFly mitral TEER system in degenerative and functional mitral regurgitation
-
14:53-14:57讨论与互动Discussion and audience interaction
-
14:57-15:00